Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast Cancer
Data up to Jan 2025
Total Citations Per Year
Abstract
References (24)
The benefits and harms of breast cancer screening: an independent review
2012 • 1,358 citations
Association analysis identifies 65 new breast cancer risk loci
2017 • 1,287 citations
Polygenic susceptibility to breast cancer and implications for prevention
2002 • 902 citations
Breast Cancer Risk From Modifiable and Nonmodifiable Risk Factors Among White Women in the United States
2016 • 334 citations
Personalizing Mammography by Breast Density and Other Risk Factors for Breast Cancer: Analysis of Health Benefits and Cost-Effectiveness
2011 • 306 citations
Estimation of mean sojourn time in breast cancer screening using a Markov chain model of both entry to and exit from the preclinical detectable phase
1995 • 203 citations
Polygenic susceptibility to prostate and breast cancer: implications for personalised screening
2011 • 156 citations
Improvement in risk prediction, early detection and prevention of breast cancer in the NHS Breast Screening Programme and family history clinics: a dual cohort study
2016 • 127 citations
Cost-Effectiveness and Harm-Benefit Analyses of Risk-Based Screening Strategies for Breast Cancer
2014 • 125 citations
Breast cancer risk prediction and individualised screening based on common genetic variation and breast density measurement
2012 • 120 citations
Combined Associations of Genetic and Environmental Risk Factors: Implications for Prevention of Breast Cancer
2014 • 110 citations
Tailoring Breast Cancer Screening Intervals by Breast Density and Risk for Women Aged 50 Years or Older: Collaborative Modeling of Screening Outcomes
2016 • 100 citations
Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium
2017 • 99 citations
Implications of polygenic risk-stratified screening for prostate cancer on overdiagnosis
2015 • 94 citations
Incorporating genomics into breast and prostate cancer screening: assessing the implications
2013 • 86 citations
Cost effectiveness of the NHS breast screening programme: life table model
2013 • 76 citations
European Guide on Quality Improvement in Comprehensive Cancer Control
2017 • 55 citations
Adjusting the frequency of mammography screening on the basis of genetic risk: Attitudes among women in the UK
2015 • 55 citations
Evaluation of a Stratified National Breast Screening Program in the United Kingdom: An Early Model-Based Cost-Effectiveness Analysis
2017 • 50 citations
A Reality Check for Overdiagnosis Estimates Associated With Breast Cancer Screening
2014 • 46 citations
Public interest in and acceptability of the prospect of risk-stratified screening for breast and prostate cancer
2015 • 45 citations
Stratified Cancer Screening: The Practicalities of Implementation
2013 • 45 citations
Screening Men at Increased Risk for Prostate Cancer Diagnosis: Model Estimates of Benefits and Harms
2016 • 40 citations
Reducing overdiagnosis by polygenic risk-stratified screening: findings from the Finnish section of the ERSPC
2015 • 39 citations
Cited By (0)
No citing papers found in database